Alessia Ogareva

Alessia Ogareva has extensive experience in the pharmaceutical industry, specializing in oncology and ophthalmology. From September 2018 to September 2021, Alessia served as Global Medical Director for Ipsen, overseeing both prelaunch and launch activities for Oncology_IO combinations and established monotherapy indications. Prior to this role, Alessia was a Medical Manager in Oncology at AstraZeneca from November 2015 to September 2018 and worked as a Medical Advisor in Ophthalmology at Novartis from December 2012 to October 2015. Alessia began her career with an internship as a Medical Advisor at Janssen, focusing on the prelaunch of Zytiga® in May to November 2012. Alessia holds a Master's degree in Marketing Intelligence from HEC Paris and a PhD in Molecular Genetics from the University of Oxford.